Cochrane · systematic review · CD008566
Continuous renal replacement therapy (CRRT) for rhabdomyolysis
Zeng, X, Zhang, L, Wu, T, et al. · Cochrane Database of Systematic Reviews · 2014 · Cochrane Library
Kidney and TransplantAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
8
current version
GRADE rated
8
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 8 · 100%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Comparison
Population: patients with rhabdomyolysis
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
All‐cause mortality | RR 0.17 [0.02, 1.37] | 1 study · 43 participants | Low Downgraded: risk of bias |
Length of hospital stay | no estimate extracted | 1 study · 43 participants | Low Downgraded: risk of bias |
Serum myoglobin: day 4 | no estimate extracted | 1 study · 36 participants | Low Downgraded: risk of bias |
Serum myoglobin: day 8 | no estimate extracted | 1 study · 36 participants | Low Downgraded: risk of bias |
Serum myoglobin: day 10 | no estimate extracted | 1 study · 22 participants | Low Downgraded: risk of bias |
Serum creatinine: day 4 | no estimate extracted | 1 study · 36 participants | Low Downgraded: risk of bias |
Serum creatinine: day 8 | no estimate extracted | 1 study · 36 participants | Low Downgraded: risk of bias |
Serum creatinine: day 10 | no estimate extracted | 1 study · 22 participants | Low Downgraded: risk of bias |